Food and Drug Administration

CRN slams FDA rejection of CBD in supplements

CRN slams FDA rejection of CBD in supplements

WASHINGTON — The Council for Responsible Nutrition (CRN) on Wednesday denounced the Food and Drug Administration’s rejection of two new dietary ingredient (NDI) notifications for full-spectrum hemp extract containing cannabidiol (CBD)—and urged Congress to act on pending legislative proposals that require the agency to address the lack of regulation of hemp-derived products. The following is

Chains pull Zantac from shelves

Chains pull Zantac from shelves

NEW YORK — Pharmacy chains CVS, Walgreens and Rite Aid and other retailers are pulling heartburn medication Zantac and its store-brand versions from their shelves after the Food and Drug Administration (FDA) warned it had detected low levels of a cancer-causing chemical in samples of the drug. The actions follow the FDA’s release of a

Sharpless named acting FDA commissioner

Sharpless named acting FDA commissioner

WASHINGTON — Dr. Norman “Ned” Sharpless, director of the National Cancer Institute, will become acting commissioner of the Food and Drug Administration next month. Health and Human Services Secretary Alex Azar said Tuesday that Sharpless will take the reins of the FDA after the resignation of Scott Gottlieb. The administration is seeking a permanent replacement